Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching Oracle’s 300-page disclosures for a simple answer—like how much cloud services & license support revenue grew—can take hours. Add in multiple segments, Autonomous Database metrics, and intricate share-repurchase notes, and Oracle’s SEC filings quickly become a maze for even seasoned analysts.
Stock Titan solves that problem in one place. Our AI reads every Oracle quarterly earnings report 10-Q filing, Oracle annual report 10-K simplified, and Oracle 8-K material events explained the moment they hit EDGAR, then delivers plain-English summaries, red-flag alerts, and context. Need Oracle insider trading Form 4 transactions? You’ll see Oracle Form 4 insider transactions real-time—with visualized buy/sell trends—before the market reacts. Wondering about Oracle proxy statement executive compensation? Our platform highlights CEO pay, option grants, and performance triggers in seconds.
Here’s how professionals use the page:
- Track Oracle executive stock transactions Form 4 to gauge insider sentiment.
- Compare cloud revenue and license margins across periods without opening spreadsheets.
- Export AI-curated key points from each Oracle earnings report filing analysis for quick stakeholder briefs.
- Receive push alerts when a new 8-K details major OCI outages or acquisition announcements.
Whether you’re understanding Oracle SEC documents with AI for the first time or you need granular footnote data fast, Stock Titan’s real-time updates and expert layer of interpretation turn complex Oracle paperwork into actionable insight.
Oracle (ORCL) received a Form 144 notice for a proposed sale of 5,000 shares of common stock. The notice lists an aggregate market value of $1,403,122.87, with sales expected on 10/23/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting in four tranches: 1,286 (12/05/2023), 1,620 (08/03/2024), 1,240 (08/04/2024), and 854 (09/15/2024), totaling 5,000. The filing also notes a separate sale by Maria Smith of 5,000 shares on 10/21/2025 for $1,400,000.00.
Oracle (ORCL) received a Form 144 notice for a proposed insider sale of 49,365 shares of common stock. The filing lists an aggregate market value of $13,387,294.35, with an approximate sale date of October 28, 2025.
The shares are indicated for sale on the NYSE through APEX Clearing. The seller’s holdings include awards acquired via RSUs from Oracle on multiple dates, such as 01/07/2013, 05/31/2018, 05/31/2020, 05/31/2021, 05/31/2022, 05/31/2024, and 05/31/2025.
Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares. The filing lists an aggregate market value of $11,065,506.10, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 shares on 09/19/2025. Shares outstanding are stated as 2,841,714,000. In the past three months, the person for whose account the sale is proposed sold 21,241 shares on 09/12/2025 for gross proceeds of $6,310,864.10.
Oracle (ORCL): A holder filed a Form 144 notice to sell 5,000 shares of Oracle common stock, with an aggregate market value of $1,400,000. The planned sale is indicated for 10/21/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting from the issuer in two tranches: 3,384 shares on 09/15/2024 and 1,616 shares on 08/03/2025. A Form 144 is a notice of a proposed sale under SEC Rule 144 and does not register new securities.
Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.
This Form 144 shows a proposed sale of 19,758 common shares of Oracle Corporation (ORCL) through Fidelity Brokerage Services LLC on the
Douglas A. Kehring, Executive Vice President and Principal Financial Officer of Oracle Corp (ORCL), filed an initial Form 3 reporting his beneficial ownership. He directly owns 68,592 shares of Oracle common stock and indirectly holds 2,157.514 units through the company 401(k) plan. He also holds unvested restricted stock units totaling 212,... (213,101) RSUs from three prior grants that convert one-for-one to common shares upon settlement and vest in annual installments.
Mark Hura filed an initial Form 3 reporting his beneficial ownership in Oracle Corporation (ORCL) following his appointment as President, Global Field Operations. The filing reports 254,077 shares of Oracle common stock held directly and 162,959 unvested restricted stock units (RSUs) that each convert to one share at settlement. The RSUs come from three prior grants: 190,868 RSUs granted 09/20/2022 (vesting in four equal annual installments), 114,126 RSUs granted 09/15/2023 (four annual installments), and 77,571 RSUs granted 09/19/2024 (four annual installments).
The statement was signed by an attorney-in-fact on behalf of Mr. Hura on 10/01/2025 and reflects holdings as of the 09/22/2025 event date. All reported RSUs are unvested and scheduled to vest in equal annual tranches starting on each grant's first anniversary, indicating future potential share settlement rather than current voting shares.
Naomi O. Seligman, a director of Oracle Corporation (ORCL), reported transactions in Oracle common stock on 09/26/2025. The filing shows a sale of 2,222 shares at $288.91 (transaction code S), followed the same day by a gift of 1,406 shares (transaction code G) with no cash consideration. After those transactions the reporting person is shown as directly owning 29,225 shares following the sale and 27,819 shares following the gift. The filing discloses 6,000 shares held indirectly by spouse and 14,414 shares held indirectly by a trust. An administrative correction notes 10 shares were previously overreported. The Form 4 is signed by attorney-in-fact Aimee Weast on behalf of Ms. Seligman.